Approval · Notice of Compliance 2325 · 2001
INTRON A: Notice of Compliance 2325
Issued November 23, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2325
- Date
- November 23, 2001
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing procedure
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTRON A | Not yet assigned | — |
Medicinal ingredients
- INTERFERON ALFA 2B 15,000,000 UNIT per ML
- INTERFERON ALFA 2B 25,000,000 UNIT per ML
- INTERFERON ALFA 2B 50,000,000 UNIT per ML